SCHEMBL13459938

SCHEMBL13459938

CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(-c4cccc5c(N)nccc45)cc3)cc2C(F)(F)F)CC1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RET P07949 5/20 0.66
▸ RIPK1 Q13546 8/20 0.66
▸ KDR P35968 3/20 0.64
▸ MKNK2 Q9HBH9 4/20 0.55
▸ MKNK1 Q9BUB5 3/20 0.54
▸ SRC P12931 3/20 0.54
▸ CDK2 P24941 2/20 0.54
▸ CDK8 P49336 2/20 0.54
▸ CSF1R P07333 2/20 0.54
▸ PDGFRB P09619 2/20 0.54
▸ FLT3 P36888 2/20 0.54
▸ ABL1 P00519 2/20 0.54
▸ RAF1 P04049 2/20 0.54
▸ CDK1 P06493 1/20 0.54
▸ STK25 O00506 1/20 0.54
▸ CIT O14578 1/20 0.54
▸ MAP2K7 O14733 1/20 0.54
▸ IKBKB O14920 1/20 0.54
▸ AURKA O14965 1/20 0.54
▸ GAK O14976 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13459601 0.91 RET (0.64) RETRIPK1KDRMKNK2MKNK1
SCHEMBL13459841 0.91 RET (0.58) RETRIPK1KDRMKNK2MKNK1
SCHEMBL13459593 0.88 RET (0.64) RETRIPK1KDRMKNK2MKNK1
SCHEMBL13459818 0.85 RET (0.64) RETRIPK1KDRMKNK2MKNK1
SCHEMBL13459587 0.82 RET (0.55) RETRIPK1KDRMKNK2MKNK1
SCHEMBL27927274 0.79 ABL1 (0.60) RETKDRSRCCDK2CDK8
SCHEMBL13459820 0.79 RET (0.55) RETRIPK1KDRMKNK2MKNK1
SCHEMBL16735349 0.78 RAF1 (0.81) KDRPDGFRBRAF1EGFRBRAF
SCHEMBL24449290 0.77 ABL1 (0.61) RETKDRSRCCDK2CDK8
SCHEMBL2816963 0.77 CDK1 (0.61) RETKDRSRCCDK2CDK8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010032986-A2 NOVEL 5-(4-AMINOPHENYL)-ISOQUINOLINE DERIVATIVE, PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, PRODUCTION METHOD FOR SAME, AND COMPOSITION CONTAINING SAME AS ACTIVE INGREDIENT FOR PROPHYLAXIS AND TREATMENT OF MEDICAL CONDITION INDUCED BY RAF KINASE HYPERACTIVITY 주식회사 이큐스팜 (KR) 2010-03-25 — — WO disclosed
Send feedback